| Tag | Content |
|---|
EnhancerAtlas ID | HS109-23754 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr9:140639920-140640490 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr9:140640360-140640375 | ATTGCTGAGTCATGC | - | 8.55 | | Nfe2l2 | MA0150.2 | chr9:140640362-140640377 | TGCTGAGTCATGCCT | - | 7.3 | | SREBF2 | MA0596.1 | chr9:140639950-140639960 | ATCACCCCAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_10754 | chr9:140638878-140640811 | CD19_Primary | | SE_11232 | chr9:140638468-140641129 | CD20 | | SE_32711 | chr9:140638399-140641999 | GM12878 | | SE_59172 | chr9:140631350-140657613 | Ly3 | | SE_62965 | chr9:140561512-140658488 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH09I137744 | chr9 | 140638883 | 140641502 |
|
Enhancer Sequence | GAAGAAGCAT GAGGAAGAAA ACACAGCATC ATCACCCCAT TGTCCTGGTG GCTCTGGCAC 60
TCTGAAACAG TCACTACAGG AACTTCCTTA GACGTGCCCA GCACAGCCCA GCCCTCCCCG 120
AAGGACAGGC AGCCCTGACT GCACCGTGGG GAAGCAGCTA CCCCAGCAGC TGCCGCGGTC 180
TCTGCACACA CGTGTCTGTC GCTCCAGTGC ACTGTCTGTT CAGCTGTGTT ACGCTCTTTC 240
TGTCAAGTTA CAAGGGGTAT TCAGTGTCAC AGTTTTGCTG AGTATGCCGG AGGCTCATAA 300
GTGCTGTCTG CATTTACAGT GTAGCACTTT GATGTCACCA GGCCACCTCT GACTGTATCC 360
TTCCACCTGC AGAGACCTGA GGGGTGTGGT TTCCTCACCT TCCCCAGCAG GGCTGCCTTC 420
TTGGAGTCCA GCAGCTCTTC ATTGCTGAGT CATGCCTGGG GCTGAGCAGC CAGCCACCAG 480
TGTTTGTTCC TCTGTAAGCC GCTTGCTAAA TAGCCCCTGC TCATTTTTCT TCTGGATTTT 540
GCATCTTTTG AATGTAGTCT GACGATCTTT 570
|
